GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

GMED · Mar 31, 2024

GLOBUS MEDICAL INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001562762-24-000126General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.71% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

8.64% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

134.54% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

60.19% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

1.32% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

9.44% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

2.85% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/7 normalizedLevel 3 Jun 30, 20250/7 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20256/7 normalizedLevel 3 Mar 31, 20266/7 normalizedLevel 3 Jun 30, 20266/7 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 4.99%
Current: 4.71%
Delta: -0.28%

Cash Generation Decreased

Previous: 15.52%
Current: 8.64%
Delta: -6.89%

Inventory Pressure Increased

Previous: 54.07%
Current: 134.54%
Delta: 80.46%

Margin Decreased

Previous: 65.05%
Current: 60.19%
Delta: -4.86%

Profitability Decreased

Previous: 8.49%
Current: 1.32%
Delta: -7.17%

R And D Intensity Increased

Previous: 7.91%
Current: 9.44%
Delta: 1.53%

Sbc Intensity Decreased

Previous: 3.36%
Current: 2.85%
Delta: -0.52%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · GMED Fundamental State →Has State · GLOBUS MEDICAL INC →Transitioned To · GMED Fundamental State →Transitioned To · GMED CAPEX_INTENSITY_DECREASED →Transitioned To · GMED CASH_GENERATION_DECREASED →Transitioned To · GMED INVENTORY_PRESSURE_INCREASED →Transitioned To · GMED MARGIN_DECREASED →Transitioned To · GMED PROFITABILITY_DECREASED →Transitioned To · GMED R_AND_D_INTENSITY_INCREASED →Transitioned To · GMED SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.